OUR MISSION

Driving Innovation & Quality in Healthcare.

Experience the
LDGI Difference.

MEET THE FOUNDER

Lesley Northrop, PhD, FACMG

Founder, Managing Member of LDGI, llc & Diagnostic Guru

Executive Leader in Diagnostics | C-Suite Collaborator | Strategic Founder | Board-Ready Governance | Innovator | Entrepreneur

I am a seasoned executive and translational scientist who leverages decades of C-suite and leadership experience across biotech, diagnostics, and digital health to transform innovative science into regulated, profitable clinical diagnostic assets. As the Founder of Laboratory Diagnostics & Genomics Innovation, I specialize in providing the precise, actionable guidance required for strategic growth and market entry. I build and execute the product development pipeline from "Ideation to Commercialization"!

🧬 ABMGG - clinical molecular geneticist

👩🏼‍🔬 PhD in Neuroendocrinology & Reproduction

🥼 Licensed lab director in NYS, CA, NJ

⚙️ Built of over 13 net-new labs seeking CLIA/CAP/CLEP across 6 U.S. states and Canada

💡 Developed multiple diagnostic assays to commercialization in women's health, oncology, general wellness and sexual health.

🦸🏼‍♀️ Alchemy

"Innovation is a Meditative State of Mind"

Operational Excellence.

Whether you aim to enhance your laboratory diagnostics or pioneer new genomic solutions, we are here to support your goals with unmatched expertise and dedication. We provide quality consulting and input to assist you in meeting clinical regulatory guidelines.

Contact Now

SPECIALIZATIONS

LEADERSHIP

Developed cross-functional teams in multiple divisions including; laboratory science, Data Analytics & Bioinformatics, Medical Affairs, Clinical Affairs, Genetic Communication, Business Development, R&D, Program management, Product development
Leader in executive team management and driving company OKRs/KPIs
Strategic leader gain cross-functional alignment utilizing change management
High performing senior executive drawing on two decades of strategic leadership in product development diagnostic pipelines

INDUSTRY INSIGHTS

Executed definitive agreements with two of the largest Private Equity backed clinical supergroups in the USA
Lead scientific analyst in identifying investor backed companies with novel IP for diagnostics
Leader in distribution of decentralized products

A Scientific Advisor in diagnostics healthcare for numerous biotechnology companies including investment firms seeking financing in the industry.

INNOVATION & CREATIVITY

Designed and developed a technology transfer solution for high-throughput hereditary genetics testing including assay design and validation, cloud-based data integration portal with automated clinical report
Developed machine learning/AI algorithms utilizing Deep Neural Networks
Lead development of multiple clinical diagnostic test for commercialization in several specialities; proteomics, genomics, transcriptomics, virology and clinical chemistry

PRODUCT IDEATION TO COMMERCIALIZATION

Lead biomarker discovery program identifying unique signatures of disease and non-disease states in women’s diagnostics specific to Endometriosis, Ovarian Cancer, Endometrial Cancer
Achieved NYS LDT approval of the first Women’s Health Reproductive Risk-based NGS test
Lead scientist that helped develop the first comprehensive PGT-D test using molecular techniques. Changed the testing landscape of IVF preimplantation genetic testing.

CLINICAL LABORATORY OPERATIONS

Achieved 13 brand-new CLIA licensures across 6 State (CA, MA, NJ, CT, GA, NY) and Canada
Reduce operations COGS by 75% using high-throughput automation and AI
FDA proficient in design development protocols for algorithm and software compliance

GRANT AWARDSHIP

Lead author on $1M BIRD grant, awarded in 2020 for Synergy development